35917404|t|P301S-hTau acetylates KEAP1 to trigger synaptic toxicity via inhibiting NRF2/ARE pathway: A novel mechanism underlying hTau-induced synaptic toxicities.
35917404|a|BACKGROUND: Human Tau (hTau) accumulation and synapse loss are two pathological hallmarks of tauopathies. However, whether and how hTau exerts toxic effects on synapses remain elusive. METHODS: Mutated hTau (P301S) was overexpressed in the N2a cell line, primary hippocampal neurons and hippocampal CA3. Western blotting and quantitative polymerase chain reaction were applied to examine the protein and mRNA levels of synaptic proteins. The protein interaction was tested by co-immunoprecipitation and proximity ligation assays. Memory and emotion status were evaluated by a series of behavioural tests. The transcriptional activity of nuclear factor-erythroid 2-related factor 2 (NRF2) was detected by dual luciferase reporter assay. Electrophoresis mobility shift assay and chromosome immunoprecipitation were conducted to examine the combination of NRF2 to specific anti-oxidative response element (ARE) sequences. Neuronal morphology was analysed after Golgi staining. RESULTS: Overexpressing P301S decreased the protein levels of post-synaptic density protein 93 (PSD93), PSD95 and synapsin 1 (SYN1). Simultaneously, NRF2 was decreased, whereas Kelch-like ECH-associated protein 1 (KEAP1) was elevated. Further, we found that NRF2 could bind to the specific AREs of DLG2, DLG4 and SYN1 genes, which encode PSD93, PSD95 and SYN1, respectively, to promote their expression. Overexpressing NRF2 ameliorated P301S-reduced synaptic proteins and synapse. By means of acetylation at K312, P301S increased the protein level of KEAP1 via inhibiting KEAP1 degradation from ubiquitin-proteasome pathway, thereby decreasing NRF2 and reducing synapse. Blocking the P301S-KEAP1 interaction at K312 rescued the P301S-suppressed expression of synaptic proteins and memory deficits with anxiety efficiently. CONCLUSIONS: P301S-hTau could acetylate KEAP1 to trigger synaptic toxicity via inhibiting the NRF2/ARE pathway. These findings provide a novel and potential target for the therapeutic intervention of tauopathies.
35917404	0	5	P301S	ProteinMutation	tmVar:p|SUB|P|301|S;HGVS:p.P301S;VariantGroup:0;CorrespondingGene:4137;RS#:63751438;CorrespondingSpecies:9606;CA#:225439
35917404	22	27	KEAP1	Gene	50868
35917404	39	56	synaptic toxicity	Disease	MESH:D012183
35917404	72	76	NRF2	Gene	18024
35917404	132	151	synaptic toxicities	Disease	MESH:D012183
35917404	165	170	Human	Species	9606
35917404	171	174	Tau	Gene	4137
35917404	246	257	tauopathies	Disease	MESH:D024801
35917404	361	366	P301S	ProteinMutation	tmVar:p|SUB|P|301|S;HGVS:p.P301S;VariantGroup:0;CorrespondingGene:4137;RS#:63751438;CorrespondingSpecies:9606;CA#:225439
35917404	393	396	N2a	CellLine	CVCL:0470
35917404	790	833	nuclear factor-erythroid 2-related factor 2	Gene	18024
35917404	835	839	NRF2	Gene	18024
35917404	1006	1010	NRF2	Gene	18024
35917404	1151	1156	P301S	ProteinMutation	tmVar:p|SUB|P|301|S;HGVS:p.P301S;VariantGroup:0;CorrespondingGene:4137;RS#:63751438;CorrespondingSpecies:9606;CA#:225439
35917404	1189	1221	post-synaptic density protein 93	Gene	23859
35917404	1223	1228	PSD93	Gene	23859
35917404	1231	1236	PSD95	Gene	13385
35917404	1241	1251	synapsin 1	Gene	20964
35917404	1253	1257	SYN1	Gene	20964
35917404	1276	1280	NRF2	Gene	18024
35917404	1304	1339	Kelch-like ECH-associated protein 1	Gene	50868
35917404	1341	1346	KEAP1	Gene	50868
35917404	1385	1389	NRF2	Gene	18024
35917404	1425	1429	DLG2	Gene	23859
35917404	1431	1435	DLG4	Gene	13385
35917404	1440	1444	SYN1	Gene	20964
35917404	1465	1470	PSD93	Gene	23859
35917404	1472	1477	PSD95	Gene	13385
35917404	1482	1486	SYN1	Gene	20964
35917404	1546	1550	NRF2	Gene	18024
35917404	1563	1568	P301S	ProteinMutation	tmVar:p|SUB|P|301|S;HGVS:p.P301S;VariantGroup:0;CorrespondingGene:4137;RS#:63751438;CorrespondingSpecies:9606;CA#:225439
35917404	1641	1646	P301S	ProteinMutation	tmVar:p|SUB|P|301|S;HGVS:p.P301S;VariantGroup:0;CorrespondingGene:4137;RS#:63751438;CorrespondingSpecies:9606;CA#:225439
35917404	1678	1683	KEAP1	Gene	50868
35917404	1699	1704	KEAP1	Gene	50868
35917404	1771	1775	NRF2	Gene	18024
35917404	1811	1816	P301S	ProteinMutation	tmVar:p|SUB|P|301|S;HGVS:p.P301S;VariantGroup:0;CorrespondingGene:4137;RS#:63751438;CorrespondingSpecies:9606;CA#:225439
35917404	1817	1822	KEAP1	Gene	50868
35917404	1855	1860	P301S	ProteinMutation	tmVar:p|SUB|P|301|S;HGVS:p.P301S;VariantGroup:0;CorrespondingGene:4137;RS#:63751438;CorrespondingSpecies:9606;CA#:225439
35917404	1908	1923	memory deficits	Disease	MESH:D008569
35917404	1929	1936	anxiety	Disease	MESH:D001007
35917404	1963	1968	P301S	ProteinMutation	tmVar:p|SUB|P|301|S;HGVS:p.P301S;VariantGroup:0;CorrespondingGene:4137;RS#:63751438;CorrespondingSpecies:9606;CA#:225439
35917404	1990	1995	KEAP1	Gene	50868
35917404	2007	2024	synaptic toxicity	Disease	MESH:D012183
35917404	2044	2048	NRF2	Gene	18024
35917404	2150	2161	tauopathies	Disease	MESH:D024801
35917404	Negative_Correlation	MESH:D008569	RS#:63751438;HGVS:p.P301S;CorrespondingGene:4137
35917404	Positive_Correlation	MESH:D012183	RS#:63751438;HGVS:p.P301S;CorrespondingGene:4137
35917404	Association	MESH:D001007	RS#:63751438;HGVS:p.P301S;CorrespondingGene:4137
35917404	Association	13385	18024
35917404	Association	MESH:D008569	50868
35917404	Bind	18024	23859
35917404	Association	MESH:D024801	4137
35917404	Association	MESH:D012183	18024
35917404	Bind	18024	20964
35917404	Association	MESH:D012183	50868
35917404	Association	MESH:D001007	50868
35917404	Association	MESH:D008569	4137
35917404	Association	MESH:D012183	4137
35917404	Association	MESH:D001007	4137

